MedPath

"Adjuvant Chemotherapy Trial of S-1 for breast cancer with ER-positive and HER2-negative" Pharmacodynamics, Pharmacokinetics and Pharmacogenomics study

Not Applicable
Conditions
Female patient with invasive breast cancer
Registration Number
JPRN-UMIN000006194
Lead Sponsor
Graduate School of Medicine Kyoto University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
1400
Inclusion Criteria

Not provided

Exclusion Criteria

None

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pharmacokinetics of S-1
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath